Low Dose Statins, Ezetimibe and Nutraceuticals

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT03277079

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03277079
Other papers using this trial's data
  • Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment The American journal of cardiology, 2019-01-15 DOI, PubMed 30420184

Courtesy of the U.S. National Library of Medicine.

Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03277079. Randomized; single masking; primary purpose treatment. Start 2017-10-01 (anticipated); primary completion 2017-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low Dose Statins, Ezetimibe and Nutraceuticals
Acronym
TACO
Intervention (Drug)
statin + ezetimibe
Intervention (Drug)
statin + ezetimibe + Nutraceuticals
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct03277079
Content hash
6de1dfe27fc153ffb9f3c69dc3513fffc58d547b20c899b27e2f1049b963e8f2